COVID-19, mRNA and Moderna
Moderna Receives EU Tender Order for Covid-19 Vaccine
Under the agreement, 17 participating countries could order an updated version of the biotech company's mRNA Covid-19 vaccine for up to four years. The vaccine, marketed as Spikevax in Europe, was among the world's best-selling medicines in the depths of the pandemic in 2021.
The president announced a major AI investment project, which Oracle Chairman Larry Ellison said could be used to cure cancer.
Vaxxas and CEPI advance US$ 4.8 million programme for needle-free thermostable mRNA vaccines: Cambridge, Massachusetts Friday, January 24, 2025, 14:00 Hrs [IST] Vaxxas, a clinical ...
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...
The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...
We're learning more about a massive artificial intelligence infrastructure bill announced Tuesday by President Donald Trump.
Following the lead of previous work on mRNA-based vaccines, therapies for spinal cord injuries and more, the method relies upon mineral-coated microparticles to deliver mRNA that encodes for ...
Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...
A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback